QuidelOrtho Corp QDEL
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if QDEL is a good fit for your portfolio.
News
-
QuidelOrtho to Participate in the Evercore ISI Conference
-
QuidelOrtho Reports Third Quarter 2023 Financial Results
-
Powerful Lyme Disease Awareness PSA Featuring Christopher Meloni Illuminates Times Square
-
QuidelOrtho Reports Preliminary Revenue Results for the Third Quarter 2023
-
QuidelOrtho Receives CLIA Waiver for Sofia® 2 SARS Antigen+ FIA
Trading Information
- Previous Close Price
- $66.85
- Day Range
- $64.73–67.35
- 52-Week Range
- $57.54–102.00
- Bid/Ask
- $63.66 / $68.33
- Market Cap
- $4.45 Bil
- Volume/Avg
- 432,030 / 530,586
Key Statistics
- Price/Earnings (Normalized)
- 14.10
- Price/Sales
- 1.43
- Dividend Yield
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make better decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if the revenue from North America.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 7,000
- Website
- https://www.quidelortho.com
Valuation
|
Metric
|
QDEL
|
|---|---|
Price/Earnings (Normalized) | 14.10 |
Price/Book Value | 0.90 |
Price/Sales | 1.43 |
Price/Cash Flow | 8.92 |
Price/Earnings
QDEL
Financial Strength
|
Metric
|
QDEL
|
|---|---|
Quick Ratio | 0.83 |
Current Ratio | 1.59 |
Interest Coverage | 1.10 |
Quick Ratio
QDEL
Profitability
|
Metric
|
QDEL
|
|---|---|
Return on Assets (Normalized) | 3.65% |
Return on Equity (Normalized) | 6.41% |
Return on Invested Capital (Normalized) | 5.44% |
Return on Assets
QDEL
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|
ABT
| Abbott Laboratories | Vwvhntn | $180.6 Bil | |
SYK
| Stryker Corp | Yxsg | $109.9 Bil | |
MDT
| Medtronic PLC | Lsrx | $105.8 Bil | |
BSX
| Boston Scientific Corp | Mrcjzcy | $80.6 Bil | |
DXCM
| DexCom Inc | Tmsk | $45.4 Bil | |
EW
| Edwards Lifesciences Corp | Jbycyby | $41.4 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Zdmkc | $24.5 Bil | |
PHG
| Koninklijke Philips NV ADR | Ltxxbc | $18.1 Bil | |
ALGN
| Align Technology Inc | Snspyh | $16.6 Bil | |
PODD
| Insulet Corp | Nyfght | $13.6 Bil |